Related Experiment Video
Updated: Feb 6, 2026

10:11
Whole-Body Nanoparticle Aerosol Inhalation Exposures
Published on: May 7, 2013
16.3K
Inhaled Technosphere Insulin in Children with Diabetes: The INHALE-1 Extension Study
Roy W Beck1, Lauren Kanapka1, Roshanak Monzavi2
1JAEB Center for Health Research, Tampa, Florida, USA.
Diabetes Technology & Therapeutics
|February 5, 2026
Summary
The INHALE-1 extension study found technosphere insulin (TI) safe for children with diabetes over 52 weeks. While HbA1c slightly increased, TI offers a viable option for pediatric patients, especially those avoiding AID systems.
Area of Science:
- Pediatric Endocrinology
- Diabetes Management
- Pharmacology
Background:
- The INHALE-1 trial assessed technosphere insulin (TI) in children with diabetes.
- An extension phase was conducted to gather long-term safety data for TI.
Purpose of the Study:
- To evaluate the long-term safety and efficacy of technosphere insulin (TI) in pediatric patients with diabetes.
- To provide extended safety data following the initial INHALE-1 randomized controlled trial.
Main Methods:
- Children aged 4-17 with type 1 or type 2 diabetes were randomized to TI or rapid-acting analog (RAA) plus basal insulin and CGM.
- Participants could enter a 52-week extension phase, using TI in both groups.
Main Results:
- No serious pulmonary adverse events were reported with TI use.
- HbA1c levels showed a slight deterioration (0.38% in TI group, 0.31% in RAA crossover group) from 26 to 52 weeks.
- Continuous glucose monitoring showed minimal time below 54 mg/dL during TI use.
Conclusions:
- The INHALE-1 extension phase confirmed no safety concerns with TI in pediatric diabetes patients.
- TI may be a beneficial treatment option for children with diabetes, particularly those unable or unwilling to use automated insulin delivery (AID) systems.
- Despite a slight increase in HbA1c, TI's safety profile and reported patient satisfaction suggest its utility.
Related Concept Videos
Inhaled Medications
803
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
803
Pulmonary Ventilation: Inhalation
8.2K
Pulmonary ventilation is a vital process that ensures the exchange of oxygen and carbon dioxide in the lungs. It refers to the movement of air into and out of the lungs, enabling the body to obtain oxygen and remove waste carbon dioxide. In this article, we will explore the intricacies of pulmonary ventilation, including its underlying principles, mechanisms, and the interplay of pressures within the respiratory system.
Boyle's law becomes particularly pertinent when examining respiratory...
Boyle's law becomes particularly pertinent when examining respiratory...
8.2K
Inhalational Anesthetics: Overview
1.1K
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.1K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.6K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.6K
Pathophysiology of Diabetes
3.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
Insulin Secretory Vesicles
7.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.0K

